RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for ...
Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterised by redness, itching, and the formation of vesicles on the hands that can result in pain and a significant ...
Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...
Current treatments for chronic hand eczema (CHE) generally fall into two buckets: Either they battle inflammation but lead to unwanted side effects with long-term use or they soothe external ...
In this multicenter double blind trial presented at the 2024 Fall Clinical Dermatology Conference, treatment success defined as an Investigator’s Global Assessment-Chronic Hand Eczema score of 0 ...
The following is a summary of “Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic ...
“Red light therapy is an energy-based modality that uses specific wavelengths of red and near-infrared light (typically ...
RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for 12 of 15 patients within four weeks. The condition primarily affects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback